Literature DB >> 16804969

Curcumin-attenuated trinitrobenzene sulphonic acid induces chronic colitis by inhibiting expression of cyclooxygenase-2.

Hua Jiang1, Chang-Sheng Deng, Ming Zhang, Jian Xia.   

Abstract

AIM: To explore the possible mechanisms of curcumin in rat colitis induced by trinitrobenzene sulfonic (TNBS) acid.
METHODS: Rats with TNBS acid-induced colitis were treated with curcumin (30 mg/kg or 60 mg/kg per day ip). Changes of body weight and histological scores as well as survival rate were evaluated. Leukocyte infiltration was detected by myeloperoxidase (MPO) activity assay. The expression of cyclooxygenase-2 (COX-2) was detected by RT-PCR and Western blot. Inflammation cytokines were determined by RT-PCR. Local concentration of prostaglandin E(2) (PGE(2)) in colon mucosa was determined by ELISA.
RESULTS: Curcumin improved survival rate and histological image, decreased the macroscopic scores and MPO activity. Also curcumin reduced the expression of COX-2 and inflammation cytokines. In addition, treatment with curcumin increased the PGE(2) level.
CONCLUSION: Curcumin has therapeutic effects on TNBS acid-induced colitis, the mechanisms seem to be related to COX-2 inhibition and PGE(2) improvement.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16804969      PMCID: PMC4087932          DOI: 10.3748/wjg.v12.i24.3848

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  30 in total

1.  A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group.

Authors:  S R Targan; S B Hanauer; S J van Deventer; L Mayer; D H Present; T Braakman; K L DeWoody; T F Schaible; P J Rutgeerts
Journal:  N Engl J Med       Date:  1997-10-09       Impact factor: 91.245

2.  Hapten-induced model of chronic inflammation and ulceration in the rat colon.

Authors:  G P Morris; P L Beck; M S Herridge; W T Depew; M R Szewczuk; J L Wallace
Journal:  Gastroenterology       Date:  1989-03       Impact factor: 22.682

Review 3.  Pharmacology of Curcuma longa.

Authors:  H P Ammon; M A Wahl
Journal:  Planta Med       Date:  1991-02       Impact factor: 3.352

4.  Aggravation of inflammatory bowel disease by cyclooxygenase-2 inhibitors in rats.

Authors:  Vijay Pal Singh; Chandrashekhar S Patil; Naveen K Jain; Shrinivas K Kulkarni
Journal:  Pharmacology       Date:  2004-10       Impact factor: 2.547

5.  Inflixmab as a possible treatment for the hemorrhagic type of Crohn's disease.

Authors:  Tomoyuki Tsujikawa; Riichiro Nezu; Akira Andoh; Takao Saotome; Yoshio Araki; Yoshiyuki Ishizuka; Masaya Sasaki; Shigeki Koyama; Yoshihide Fujiyama
Journal:  J Gastroenterol       Date:  2004       Impact factor: 7.527

6.  Suppression of dextran sodium sulfate-induced colitis in mice by zerumbone, a subtropical ginger sesquiterpene, and nimesulide: separately and in combination.

Authors:  Akira Murakami; Ryohei Hayashi; Takuji Tanaka; Ki Han Kwon; Hajime Ohigashi; Ratu Safitri; Takuji Takana
Journal:  Biochem Pharmacol       Date:  2003-10-01       Impact factor: 5.858

7.  Inhibitory effects of curcumin on in vitro lipoxygenase and cyclooxygenase activities in mouse epidermis.

Authors:  M T Huang; T Lysz; T Ferraro; T F Abidi; J D Laskin; A H Conney
Journal:  Cancer Res       Date:  1991-02-01       Impact factor: 12.701

8.  Suppression of c-Jun/AP-1 activation by an inhibitor of tumor promotion in mouse fibroblast cells.

Authors:  T S Huang; S C Lee; J K Lin
Journal:  Proc Natl Acad Sci U S A       Date:  1991-06-15       Impact factor: 11.205

9.  Curcumin suppresses lipopolysaccharide-induced cyclooxygenase-2 expression by inhibiting activator protein 1 and nuclear factor kappab bindings in BV2 microglial cells.

Authors:  Gu Kang; Pil-Jae Kong; Young-Jin Yuh; So-Young Lim; Sung-Vin Yim; Wanjoo Chun; Sung-Soo Kim
Journal:  J Pharmacol Sci       Date:  2004-03       Impact factor: 3.337

10.  Regulation of T helper type-1 immunity in hapten-induced colitis by host pretreatment with granulocyte colony-stimulating factor.

Authors:  Hiroyuki Egi; Keisuke Hayamizu; Masanori Yoshimitsu; Fumio Shimamoto; Koichi Oishi; Ichiro Ohmori; Masazumi Okajima; Toshimasa Asahara
Journal:  Cytokine       Date:  2003-07       Impact factor: 3.861

View more
  23 in total

Review 1.  Polyphenols in the treatment of inflammatory bowel disease and acute pancreatitis.

Authors:  Haim Shapiro; Pierre Singer; Zamir Halpern; Rafael Bruck
Journal:  Gut       Date:  2006-08-24       Impact factor: 23.059

2.  Effects of curcumin and Ginkgo biloba on matrix metalloproteinases gene expression and other biomarkers of inflammatory bowel disease.

Authors:  Tarek Kamal Motawi; Sherine Maher Rizk; Ahmed Hassan Shehata
Journal:  J Physiol Biochem       Date:  2012-04-26       Impact factor: 4.158

3.  Modulation of neutrophil motility by curcumin: implications for inflammatory bowel disease.

Authors:  C B Larmonier; M T Midura-Kiela; R Ramalingam; D Laubitz; N Janikashvili; N Larmonier; F K Ghishan; P R Kiela
Journal:  Inflamm Bowel Dis       Date:  2011-02       Impact factor: 5.325

Review 4.  "Spicing up" of the immune system by curcumin.

Authors:  Ganesh Chandra Jagetia; Bharat B Aggarwal
Journal:  J Clin Immunol       Date:  2007-01-09       Impact factor: 8.317

Review 5.  Probiotics, fibre and herbal medicinal products for functional and inflammatory bowel disorders.

Authors:  Diego Currò; Gianluca Ianiro; Silvia Pecere; Stefano Bibbò; Giovanni Cammarota
Journal:  Br J Pharmacol       Date:  2016-10-25       Impact factor: 8.739

6.  The Use of Curcumin for the Treatment of Renal Disorders: A Systematic Review of Randomized Controlled Trials.

Authors:  Mohammad Bagherniya; Davood Soleimani; Mohammad Hossein Rouhani; Gholamreza Askari; Thozhukat Sathyapalan; Amirhossein Sahebkar
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

7.  Limited effects of dietary curcumin on Th-1 driven colitis in IL-10 deficient mice suggest an IL-10-dependent mechanism of protection.

Authors:  C B Larmonier; J K Uno; Kang-Moon Lee; T Karrasch; D Laubitz; R Thurston; M T Midura-Kiela; F K Ghishan; R B Sartor; C Jobin; P R Kiela
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2008-09-25       Impact factor: 4.052

Review 8.  Curcumin: an orally bioavailable blocker of TNF and other pro-inflammatory biomarkers.

Authors:  Bharat B Aggarwal; Subash C Gupta; Bokyung Sung
Journal:  Br J Pharmacol       Date:  2013-08       Impact factor: 8.739

9.  Oral administration of curcumin emulsified in carboxymethyl cellulose has a potent anti-inflammatory effect in the IL-10 gene-deficient mouse model of IBD.

Authors:  Victoria Y L Ung; Rae R Foshaug; Sarah M MacFarlane; Thomas A Churchill; Jason S G Doyle; Beate C Sydora; Richard N Fedorak
Journal:  Dig Dis Sci       Date:  2009-06-10       Impact factor: 3.199

10.  Effect of COX-2 inhibitor after TNBS-induced colitis in Wistar rats.

Authors:  Ana Paula Ribeiro Paiotti; Sender Jankiel Miszputen; Celina Tizuko Fujiyama Oshima; Henrique de Oliveira Costa; Daniel Araki Ribeiro; Marcello Franco
Journal:  J Mol Histol       Date:  2009-11-22       Impact factor: 2.611

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.